TAp73 expression and P1 promoter methylation, a potential marker for chemoresponsiveness to cisplatin therapy and survival in muscle-invasive bladder cancer (MIBC)-Reference-Cited by-同舟云学术

TAp73 expression and P1 promoter methylation, a potential marker for chemoresponsiveness to cisplatin therapy and survival in muscle-invasive bladder cancer (MIBC)

Published:2019-07-18 Issue:17 Volume:18 Page:2055-2066
ISSN:1538-4101
Container-title:Cell Cycle
language:en
Short-container-title:Cell Cycle

Author:

Bunch Brittany¹,Krishnan Nithya¹,Greenspan Rebecca D.¹,Ramakrishnan Swathi¹,Attwood Kristopher²,Yan Li²,Qi Qianya²,Wang Dan²,Morrison Carl³,Omilian Angela³^ORCID,Bshara Wiam³,Pili Roberto⁴,Trump Donald L.⁵,Johnson Candace¹,Woloszynska Anna¹

Affiliation:

1. Department of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, USA

2. Department of Bioinformatics and BioStatistics, Roswell Park Comprehensive Cancer Center, Buffalo, USA

3. Department of Pathology, Roswell Park Comprehensive Cancer Center, Buffalo, USA

4. Department of Medicine, Indiana University, Buffalo, USA

5. Inova Schar Cancer Institute, Falls Church, VA, USA

Publisher

Informa UK Limited

Subject

Cell Biology,Developmental Biology,Molecular Biology

Link

https://www.tandfonline.com/doi/pdf/10.1080/15384101.2019.1638693

Reference34 articles.

1. Cancer statistics, 2019

2. Treatment of Muscle-invasive and Metastatic Bladder Cancer: Update of the EAU Guidelines

3. Perioperative chemotherapy for muscle-invasive bladder cancer

4. Neoadjuvant Chemotherapy plus Cystectomy Compared with Cystectomy Alone for Locally Advanced Bladder Cancer

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Tumor‐Derived Extracellular Vesicles in Drug Resistance in Urologic Cancers;Advanced Therapeutics;2024-05-25

2. Role of Epigenetics for the Efficacy of Cisplatin;International Journal of Molecular Sciences;2024-01-17

3. Regulation of cisplatin resistance in bladder cancer by epigenetic mechanisms;Drug Resistance Updates;2023-05

4. Syngeneic model of carcinogen-induced tumor mimics basal/squamous, stromal-rich, and neuroendocrine molecular and immunological features of muscle-invasive bladder cancer;Frontiers in Oncology;2023-02-03

5. NXPH4 Used as a New Prognostic and Immunotherapeutic Marker for Muscle-Invasive Bladder Cancer;Journal of Oncology;2022-10-04